Ashutosh Kulkarni

Ashutosh Kulkarni is an experienced professional in the field of clinical pharmacology and development, currently serving as Project Director II for Early Portfolio Strategy and Operations at Allergan Aesthetics, an AbbVie Company since May 2024. Prior to this role, Ashutosh worked as a self-employed clinical pharmacology and non-clinical development consultant from September 2023 to May 2024, and held the position of Vice President - Clinical Pharmacology at Ventyx Biosciences from January to August 2023. Ashutosh also served as Executive Director and Head of Clinical Pharmacology and DMPK at Stealth Biotech PBC from August 2021 to December 2022, and as Executive Director of Clinical Pharmacology at AbbVie following the acquisition of Allergan from May 2020 to July 2021. Ashutosh holds a PhD in Pharmaceutical Sciences from the University of Southern California and an Executive MBA in Healthcare and Digital Transformation from the University of California, Irvine - The Paul Merage School of Business.